Albuterol sulfate and budesonide

FDA Drug Profile — AIRSUPRA

Drug Details

Generic Name
Albuterol sulfate and budesonide
Brand Names
AIRSUPRA
Application Number
NDA214070
Sponsor
AstraZeneca Pharmaceuticals LP
NDC Codes
1
Dosage Forms
AEROSOL, METERED
Routes
RESPIRATORY (INHALATION)
Active Ingredients
ALBUTEROL SULFATE, BUDESONIDE

Indications and Usage

1 INDICATIONS AND USAGE AIRSUPRA is indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older. AIRSUPRA is a combination of albuterol, a beta 2 -adrenergic agonist and budesonide, a corticosteroid, indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older. ( 1 )